| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2023 ( Subtotal = $1,144,308 ) |
| | 2023 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01AI148362 | HBV RNaseH inhibitors: Effects on HBV biology and resistance development | 000 | 4 | NIH | 11/16/2022 | $378,750 |
| | 2023 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01AI150610 | Lead optimization of Hepatitis B Virus ribonuclease H inhibitors | 000 | 3 | NIH | 11/2/2022 | $637,836 |
| | 2023 | 2023 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01GM111835 | Automation of the chemical synthesis of human milk oligosaccharides | 000 | 9 | NIH | 11/23/2022 | $264,432 |
| | 2023 | 2022 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01CA271033 | Actions for Collaborative Community Engaged Strategies for HPV (ACCESS HPV) | 000 | 1 | NIH | 10/31/2022 | $0 |
| | 2023 | 2022 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | CE146490 | Community Project Funding/Congressionally Directed Spending - Construction | 01 | 1 | HRSA | 11/7/2022 | $0 |
| | 2023 | 2022 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | UM1AI148685 | Vaccine and Treatment Evaluation Unit at Saint Louis University | 000 | 3 | NIH | 10/21/2022 | $0 |
| | 2023 | 2022 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01DE025141 | Developing new therapeutic strategies against head and neck cancer | 001 | 6 | NIH | 11/9/2022 | $26,415 |
| | 2023 | 2020 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01DA043543 | Role of opioid-induced S1P/S1PR1 axis activation in neuroinflammatory reponses | 000 | 3 | NIH | 11/1/2022 | $0 |
| | 2023 | 2019 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01GM112188 | Selective regulation of the calcium component of the ATP-gated P2X7 current | 000 | 4 | NIH | 11/5/2022 | -$741 |
| | 2023 | 2019 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01DE025141 | Developing new therapeutic strategies against head and neck cancer | 000 | 5 | NIH | 11/9/2022 | -$26,415 |
| | 2023 | 2019 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | U01DK082871 | Midwest Hepatitis B Consortium | 000 | 12 | NIH | 11/2/2022 | -$135,969 |
|
| Issue Date FY: 2022 ( Subtotal = $28,474,300 ) (Continued on the next page) |
| | 2022 | 2022 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | F30CA254215 | Targeting Rad18-dependent replication stress pathways to modulate chemoresponse in BRCA1-deficient cancers | 000 | 3 | NIH | 7/18/2022 | $51,752 |
| | 2022 | 2022 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R21AI171734 | Role of RNA-binding protein in immune evasion of Mtb in macrophages | 000 | 1 | NIH | 6/3/2022 | $189,375 |
| | 2022 | 2022 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R15GM148915 | Novel Systems Biology Methods for the Cell-type-specific Regulatory Networks Reconstruction from scRNA-seq Data | 000 | 1 | NIH | 9/20/2022 | $454,500 |
| | 2022 | 2022 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01DK118340 | Integrative Physiology of Obesity: Role of GPR160 | 000 | 5 | NIH | 7/14/2022 | $378,750 |
| | 2022 | 2022 | Saint Louis University | One North Grand | Saint Louis | MO | 63103-2006 | SAINT LOUIS CITY | USA | MC142100 | Behavioral Health Workforce Education and Training Program- American Rescue Plan | 01 | 2 | HRSA | 7/14/2022 | $0 |
| | 2022 | 2022 | Saint Louis University | One North Grand | Saint Louis | MO | 63103-2006 | SAINT LOUIS CITY | USA | MC142100 | Behavioral Health Workforce Education and Training Program- American Rescue Plan | 00 | 2 | HRSA | 5/13/2022 | $459,478 |
| | 2022 | 2022 | Saint Louis University | One North Grand | Saint Louis | MO | 63103-2006 | SAINT LOUIS CITY | USA | T7635369 | Maternal and Child Health Public Health Training Program | 00 | 3 | HRSA | 4/4/2022 | $349,865 |
| | 2022 | 2022 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01GM143179 | Mechanism and Regulation of eIF6 in Translation | 000 | 1 | NIH | 7/7/2022 | $311,246 |
| | 2022 | 2022 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | F99CA274696 | Role of nuclear chaperones in genomic instability and carcinogenesis | 000 | 1 | NIH | 7/25/2022 | $33,752 |
| | 2022 | 2022 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | F30NS124254 | TBI-induced adenosinergic dysregulation causes cognitive impairment and accelerates Alzheimer's disease pathology | 000 | 1 | NIH | 5/23/2022 | $35,036 |
| | 2022 | 2022 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | F30NS124254 | TBI-induced adenosinergic dysregulation causes cognitive impairment and accelerates Alzheimer's disease pathology | 001 | 1 | NIH | 5/23/2022 | $0 |
| | 2022 | 2022 | SAINT LOUIS UNIVERSITY | ONE NORTH GRAND | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01GM111835 | Automation of the chemical synthesis of human milk oligosaccharides | 000 | 8 | NIH | 12/20/2021 | $277,357 |
| | 2022 | 2022 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01GM111835 | Automation of the chemical synthesis of human milk oligosaccharides | 004 | 8 | NIH | 6/27/2022 | $30,819 |
| | 2022 | 2022 | SAINT LOUIS UNIVERSITY | ONE NORTH GRAND | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01AI168543 | Th9 cells and protective TB immunity | 000 | 1 | NIH | 3/9/2022 | $667,594 |
| | 2022 | 2022 | SAINT LOUIS UNIVERSITY | ONE NORTH GRAND | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01EY031008 | Iron and Diabetic Retinopathy | 000 | 3 | NIH | 2/3/2022 | $367,388 |
| | 2022 | 2022 | SAINT LOUIS UNIVERSITY | ONE NORTH GRAND | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01DK125048 | The role of FSP27b on dietary lipid absorption, lipoprotein secretion, and oxidative metabolism | 001 | 3 | NIH | 3/29/2022 | $34,088 |
| | 2022 | 2022 | SAINT LOUIS UNIVERSITY | ONE NORTH GRAND | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01DK122401 | SELECTION OF VACCINE ANTIGENS FOR PROTECTION FROM HEPATITIS C VIRUS INFECTION | 000 | 3 | NIH | 4/12/2022 | $340,875 |
| | 2022 | 2022 | SAINT LOUIS UNIVERSITY | ONE NORTH GRAND | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01DK125048 | The role of FSP27b on dietary lipid absorption, lipoprotein secretion, and oxidative metabolism | 000 | 3 | NIH | 1/19/2022 | $306,787 |
| | 2022 | 2022 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R56AG076145 | Role of self-DNA and sterile inflammation driving age/progeria-related metabolic defects | 000 | 1 | NIH | 9/20/2022 | $310,366 |
| | 2022 | 2022 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R56HL165199 | Insulin regulation of lymphatic vessel integrity | 000 | 1 | NIH | 9/19/2022 | $366,522 |
| | 2022 | 2022 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01ES034383 | Halolipid-Neutrophil Extracellular Trap Axis in Halogen Lung Injury | 000 | 1 | NIH | 8/17/2022 | $462,883 |
| | 2022 | 2022 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R25AI170379 | NIAID STAR: Stimulating Training and Access to Research Experiences for Minority and Underrepresented Populations | 000 | 1 | NIH | 8/18/2022 | $352,944 |
| | 2022 | 2022 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01CA271033 | Actions for Collaborative Community Engaged Strategies for HPV (ACCESS HPV) | 000 | 1 | NIH | 9/22/2022 | $566,886 |
| | 2022 | 2022 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01CA261979 | Fingolimod and Ozanimod for the treatment and prevention of chemobrain | 000 | 1 | NIH | 9/2/2022 | $442,415 |
| | 2022 | 2022 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | F31AI172229 | Defining the impact of complement inhibition by tick saliva in tick-borne virus evolution and adaptive immune responses in murine models of infection | 000 | 1 | NIH | 7/1/2022 | $35,468 |
| | 2022 | 2022 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | S10OD032206 | Liquid chromatography and mass spectrometry instrument system | 000 | 1 | NIH | 5/25/2022 | $249,528 |
| | 2022 | 2022 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01NS128004 | Uncovering the roles of oxysterols in neuropathic pain | 000 | 1 | NIH | 7/5/2022 | $520,274 |
| | 2022 | 2022 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | T32GM141602 | Pharmacological Sciences Training Grant | 000 | 1 | NIH | 5/23/2022 | $240,786 |
| | 2022 | 2022 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01HL160553 | Clinically Meaningful PTSD Improvement: Reducing Risk for Adverse Outcomes in Comorbid Cardiometabolic Disease | 000 | 1 | NIH | 8/12/2022 | $451,447 |
| | 2022 | 2022 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R21HD107596 | Exploration of the role of CART/GPR160 in metabolism in the setting of Magel2 deficiency: Implications for Prader Willi Syndrome | 000 | 1 | NIH | 6/10/2022 | $227,250 |
| | 2022 | 2022 | Saint Louis University | One North Grand | Saint Louis | MO | 63103-2006 | SAINT LOUIS CITY | USA | CE146490 | Community Project Funding/Congressionally Directed Spending - Construction | 00 | 1 | HRSA | 8/2/2022 | $500,000 |
| | 2022 | 2022 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R01AG078822 | Metabolic Control of T Cell Senescence in Pathogenesis and Immunotherapy of Alzheimer's Disease | 000 | 1 | NIH | 8/29/2022 | $378,750 |
| | 2022 | 2022 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R37CA265877 | Novel molecular mechanism for extracellular release of proteins implicated in metastatic cancer | 000 | 1 | NIH | 8/9/2022 | $430,794 |
| | 2022 | 2022 | SAINT LOUIS UNIVERSITY | ONE NORTH GRAND | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R21AI169487 | Role of intestinal microbiota in driving injury mechanisms in short bowel syndrome | 000 | 1 | NIH | 2/25/2022 | $214,010 |
| | 2022 | 2022 | SAINT LOUIS UNIVERSITY | ONE NORTH GRAND | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | R21CA263428 | Pre-clinical testing the effects of MALT1 inhibitor on endocrine resistant breast cancer | 000 | 1 | NIH | 2/24/2022 | $186,877 |
| | 2022 | 2022 | SAINT LOUIS UNIVERSITY | ONE NORTH GRAND | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | UM1AI148685 | Vaccine and Treatment Evaluation Unit at Saint Louis University | 002 | 3 | NIH | 2/17/2022 | $151,855 |
| | 2022 | 2022 | SAINT LOUIS UNIVERSITY | 221 N GRAND BLVD | SAINT LOUIS | MO | 63103-2006 | SAINT LOUIS CITY | USA | UM1AI148685 | Vaccine and Treatment Evaluation Unit at Saint Louis University | 010 | 3 | NIH | 8/22/2022 | $1,780,596 |
|
